Search for: "Eli Lilly " Results 1141 - 1160 of 2,131
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Oct 2011, 2:52 am by Laura Sandwell
Human Genome Sciences Inc v Eli Lilly and Company, heard 18 July 2011. [read post]
18 Oct 2011, 1:47 pm
Eli Lilly & Company (civil case) [uploaded: 10/18/2011] [read post]
18 Oct 2011, 8:17 am by jleaming@acslaw.org
Within the last five years alone, Pfizer, AstraZeneca, Boston Scientific, Eli Lilly, and Biovail paid a combined total of $4.3 billion to settle claims of unlawful marketing. [read post]
9 Oct 2011, 4:35 pm by Lawrence B. Ebert
Merck, Johnson & Johnson, Eli Lilly and Bristol-Myers Squibb also cut jobs. [read post]
7 Oct 2011, 4:18 am by Marie Louise
Eli Lilly and Co (Docket Report) Faruno – Furuno files new 337 complaint regarding Certain Navigation Products (ITC 337 Law Blog) (ITC 337 Update) FlashPoint Technology – ITC issues public version of ALJ Luckern Final Initial and Recommended Determinations in Certain Electronic Imaging Devices (337-TA-726) (ITC 337 Law Blog) HTC – ITC institutes investigation (337-TA-808) against Apple regarding Certain Electronic Devices With Communication Capabilities (ITC 337… [read post]
4 Oct 2011, 8:52 am by Stefanie Levine
Armitage's, of Eli Lilly and Company, presentation entitled "A New 102: Reform, Not Recodification". [read post]
4 Oct 2011, 8:52 am by Stefanie Levine
Armitage's, of Eli Lilly and Company, presentation entitled "A New 102: Reform, Not Recodification". [read post]
29 Sep 2011, 7:44 pm
A Reading, Massachusetts is the latest plaintiff of a Boston personal injury lawsuit seeking damages from drug manufacturers, including ex-DES drur makers Bristol-Myers Squibb and Eli Lilly, for her breast cancer. [read post]
28 Sep 2011, 2:00 am by Stefanie Levine
Armitage’s, of Eli Lilly and Company, presentation entitled ”A New 102: Reform, Not Recodification”…. [read post]
28 Sep 2011, 2:00 am by Stefanie Levine
Armitage’s, of Eli Lilly and Company, presentation entitled ”A New 102: Reform, Not Recodification”…. [read post]
28 Sep 2011, 1:56 am by Marie Louise
(Kluwer Patent Blog) Gabitril (Tiagabine) – US: Cephalon files suits against Sun Pharma. in New Jersey and Michigan in response to Para IV certification (Patent Docs) Glivec (Imatinib) – India: Novartis Glivec patent case: preliminary objection (Spicy IP) Lovenox (Enoxaparin) – US: Momenta files patent infringement complaint against Amphastar in response to impending launch of generic Lovenox (Patent Docs) Lumigan (Bimatoprost) – US: Validity of Allergan Lumigan patents… [read post]
22 Sep 2011, 3:39 am by Bob Kraft
” The story reports on payments by Eli Lilly and Co., down 46 percent since 2009; GlaxoSmithKline down 29 percent. [read post]
20 Sep 2011, 3:52 am by Bob Kraft
" The story reports on payments by Eli Lilly and Co., down 46 percent since 2009; GlaxoSmithKline down 29 percent. [read post]
18 Sep 2011, 5:57 pm
Eli Lilly and Co. spent the most on speakers, $61.5 million, and had about half the sales of Pfizer. [read post]
17 Sep 2011, 5:43 am by Jonathan Rosenfeld
., Takeda Pharmaceuticals International Inc and Eli Lilly and Company), was negligent for not providing any warnings regarding the increased bladder cancer risk associated with Actos use. [read post]
14 Sep 2011, 8:21 am by Bexis
Eli Lilly & Co., 99 F.R.D. 126, 128 (D.D.C. 1983).Notwithstanding that informal interviews are permissible, a DC plaintiff attorney wanted to order his client’s treater not to speak to defense counsel (even if the doctor wanted to). [read post]